It’s impossible to calculate the impact that the 2014 World Stem Cell Summit had on San Antonio, but the exposure to national and international bioscience industry leaders and investors was significant enough that the Alamo City has boots on the ground in Atlanta this week in an effort to recapture the global event.
Recent Posts
- Improving CAR-T therapy from within
- ‘A cure on the horizon’: Are we finally close to ending type 1 diabetes?
- Scientists create “smart” DNA drug that targets cancer cells with extreme precision
- Patient deaths prompt concern over regenerative care not covered by insurance
- Biotech IPOs Rebound as AI Takes a More Central Role in Drug Development
- Clinical trial tests new cell therapy to manage kidney transplant rejection


